SEARCH HEALTH CONDITIONS BY ALPHABETS
Pathological Hypersecretory Conditions
Medications for Pathological Hypersecretory Conditions
About Pathological Hypersecretory Requirements: Pathological Hypersecretory Conditions are conditions characterized by an abnormal excessive secretion of a chemical made by the human anatomy
Drugs Used to Treat Pathological Hypersecretory Conditions
This listing of medications have been utilized at the treating this particular condition, or in some way related to.
Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
Nexium | Rx | C | N | Add review | 0.0 | ||
Generic name: esomeprazole systemic Medicine class: proton pump inhibitors For consumers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
ranitidine | Rx/OTC | B | N | 2 testimonials | 8.0 | ||
Generic name: ranitidine systemic Brand titles: Zantac, Zantac 150, Deprizine, Careone Acid Reducer, Berkley and Jensen Acid Reducer Maximum Strength, Equaline Heartburn Relief, Sunmark Acid Reducer Maximum Strength...show all Drug class: H 2 antagonists For consumers: dosage, interactions, For professionals: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
esomeprazole | Rx/OTC | C | N | Add review | 0.0 | ||
Generic name: esomeprazole systemic Brand titles: Nexium, Nexium IV Medicine class: proton pump inhibitors For consumers: dosage, interactions, For professionals: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
famotidine | Rx/OTC | B | N | Add review | 0.0 | ||
Generic name: famotidine systemic Brand titles: Pepcid, Acid Controller Original Strength, Pepcid Oral Suspension, Heartburn Relief, Pepcid AC, Pepcid AC Maximum Strength, Pepcid AC Chewable Tablets, Acid Controller Maximum Strength...show all Drug class: H 2 antagonists For consumers: dosage, interactions, For professionals: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
Zantac | Rx/OTC | B | N | Add review | 0.0 | ||
Generic name: ranitidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
Zantac 150 | Rx/OTC | B | N | Inch review | 8.0 | ||
Generic name: ranitidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
Deprizine | Rx/OTC | B | N | Add review | 0.0 | ||
Generic name: ranitidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
Pepcid | Rx | B | N | Add review | 0.0 | ||
Generic name: famotidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
Nexium IV | Rx | C | N | Add review | 0.0 | ||
Generic name: esomeprazole systemic Medicine class: proton pump inhibitors For consumers: dosage, interactions, side effects | |||||||
Acid Controller Original Strength | OTC | B | N | Add review | 0.0 | ||
Generic name: famotidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
Careone Acid Reducer | Rx/OTC | B | N | Add review | 0.0 | ||
Generic name: ranitidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
Pepcid Oral Suspension | Rx | B | N | Add review | 0.0 | ||
Generic name: famotidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
Berkley and Jensen Acid Reducer Maximum Strength | Rx/OTC | B | N | Add review | 0.0 | ||
Generic name: ranitidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
Equaline Heartburn Relief | Rx/OTC | B | N | Add review | 0.0 | ||
Generic name: ranitidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
Heartburn Relief | OTC | B | N | Add review | 0.0 | ||
Generic name: famotidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, side effects | |||||||
Pepcid AC | OTC | B | N | Add review | 0.0 | ||
Generic name: famotidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, side effects | |||||||
Pepcid AC Maximum Strength | OTC | B | N | Add review | 0.0 | ||
Generic name: famotidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, side effects | |||||||
Sunmark Acid Reducer Maximum Strength | Rx/OTC | B | N | Add review | 0.0 | ||
Generic name: ranitidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
Pepcid AC Chewable Tablets | OTC | B | N | Add review | 0.0 | ||
Generic name: famotidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, side effects | |||||||
Acid Controller Maximum Strength | OTC | B | N | Add review | 0.0 | ||
Generic name: famotidine systemic Drug class: H 2 antagonists For consumers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
Legend
Rx | prescription-only |
---|---|
OTC | Over the Counter |
Rx/OTC | Prescription or Over the Counter |
Off Label | This medication might not be approved by the FDA for the treatment of this particular condition. |
Pregnancy Category | |
---|---|
A | sufficient and well-controlled studies have failed to demonstrate a risk to the embryo within the first trimester of pregnancy (also there isn`t any evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown a negative effect in the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify used in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved in used in pregnant women certainly outweigh potential rewards. |
N | FDA have not classified the drug. |
Controlled Substances Act (CSA) Schedule | |
---|---|
N | Is not at the mercy of the Controlled Substances Act. |
Inch | features a higher potential for abuse. Has no currently accepted medical use in treatment in the United States. There`s just a lack of accepted safety for use under medical supervision. |
2 | features a higher potential for abuse. Includes a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Psychotherapy can result in severe physical or emotional dependency. |
3 | features a potential for abuse less than those in programs 1 and two. Includes a currently accepted medical use in treatment in the United States. Psychotherapy can lead to physical dependence or high psychological dependence. |
4 | features a very low potential for abuse relative to those in schedule 3. It`s a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | features a very low potential for abuse relative to those in schedule 4. Includes a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Infection | |
---|---|
X | Interacts with Medication. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Runciman
- S
- T
- U
- V
- W
- X
- Y
- Z
Further info
Always ask your healthcare provider to make sure the information displayed on this page applies to your circumstances.